Lundbeck, Otsuka collborate on Alzheimer's

Lundbeck and Otsuka are working together on a vaccine to combat Alzheimer's disease. This would be the duo's third Alzheimer's collaboration, and the agreement tethers the companies through Phase I.

This effort is an anti-beta amyloid vaccine that the companies expect would be used in the elderly. The companies said in a statement that the idea behind the treatment is that it could preserve cognitive function by preventing amyloid-beta deposits from accumulating.

The companies will decide next steps when Phase I ends. They expect the study to start next year.

You must be a registered member of MMM to post a comment.
close

Next Article in Channel

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.